PERSEUS Study
STUDY AND PROTOCOL NUMBER
Perseus EFC16035
STUDY DETAILS
A Phase 3, randomized, double-blind, efficacy and safety study comparing SAR442168 to placebo in participants with primary progressive multiple sclerosis (PERSEUS)
FURTHER INFORMATION
ClinicalTrials.gov Identifier: NCT04458051